Array
(
[1603126880] => Array
(
[wordfence_batchReportBlockedAttempts] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1603127100] => Array
(
[wordfence_processAttackData] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1603128414] => Array
(
[wordfence_hourly_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1603129173] => Array
(
[wp_privacy_delete_old_export_files] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1603129681] => Array
(
[wpm_update_stats] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1603157526] => Array
(
[wp_update_themes] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
[wp_update_plugins] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1603160953] => Array
(
[wp_version_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1603163873] => Array
(
[wp_session_garbage_collection] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1603175085] => Array
(
[recovery_mode_clean_expired_keys] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1603177712] => Array
(
[ai1wm_storage_cleanup] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1603183771] => Array
(
[wp_scheduled_auto_draft_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1603188911] => Array
(
[delete_expired_transients] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1603188952] => Array
(
[wpseo-reindex-links] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1603189614] => Array
(
[wordfence_daily_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1603201474] => Array
(
[wp_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1603201800] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[48e4faece6451506c4f1db7d9fe9dcf5] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1603201800
)
)
)
)
[1603210024] => Array
(
[akismet_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1603213011] => Array
(
[yoast_tracking] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1603261490] => Array
(
[wp_site_health_scheduled_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => weekly
[args] => Array
(
)
[interval] => 604800
)
)
)
[1603461000] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[ac3606b3e32df31849103d61634f83d9] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1603461000
)
)
)
)
[1603720800] => Array
(
[wordfence_email_activity_report] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
)
Etiquetas: Buena sanidad pública, Clientes, Contribución, Copagos, Coste, Epílogo, Inconvenientes, Industria farmacéutica, Instituto de Salud Carlos III, La buena sanidad pública ¿ni se compra ni se vende?, Madrid, Noviembre 2009, Política sanitaria, salud, Salud 2000, Sanidad, Servicios, Servicios públicos, Servicios públicos de salud, usuarios, Ventajas.
Etiquetas: 1 marzo 2007, Bases posológicas en oncología, Causas limitantes de la monitorización de los antineoplásicos, Contestación al Discurso de Ingreso, Discurso, Ecir, Epidemiología del cáncer, Epílogo, Factores influyentes en la individualización de la dosis en el paciente oncológico, Individualización posológica en el paciente oncológico, Instituto de España, José Luis Vila Jato, La respuesta en el paciente oncológico, Madrid, Métodos para individualizar las dosis de los antineoplásicos, Modelos para individualizar las dosis de los antineoplásicos, Parámetros Biométricos, Parámetros Farmacocinéticos, Parámetros Farmacodinámicos, Parámetros Farmacogenéticos, Parámetros Farmacoterapéuticos, Real Academia Nacional de Farmacia, salud, Sanidad, Víctor Jiménez Torres.
Etiquetas: 15 de mayo de 2007, 15/05/2007, Actividades profesionales, Epílogo, Ernesto Eseverri, Farmacéuticos y sociedades profesionales, Granada, Ideas generales, informe, Inversión de capital ajeno en estas Sociedades, Ley de sociedades profesionales, Relación con el régimen jurídico de oficinas de farmacia vigentes, salud, Sanidad, Sociedad profesional constituida íntegramente por farmacéuticos y comunidades de bienes, Sociedades mercantiles unipersonales.
.gif)